ByHeart announced a voluntarily recall two batches of its ByHeart Whole Nutrition Infant Formula during investigation into ...

A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk ...

California health officials say tests showed that ByHeart baby formula linked to a botulism outbreak contained the type of ...

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug ...

With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 ...

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...

With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for ...

Vitamin D3 may help drastically reduced the risk of having a second heart attack, a new clinical trial has found.

Several lots of the cholesterol medication atorvastatin were recalled after failed dissolution tests, according to the FDA.

The data were presented in a moderated poster session, “Change is in the Air! New Discoveries in Hypertension Treatment”, at the American Heart Association’s (AHA) Scientific Sessions 2025, taking ...

Some everyday medicines carry hidden heart risks, says Russia-based cardiologist Dr Dmitry Yaranov, who specializes in heart ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...